Template:Short description Template:About Template:Use mdy dates Template:Cs1 config Template:Main other <templatestyles src="Infobox drug/styles.css"/> {{#invoke:Infobox|infobox}}Template:Template other{{#invoke:TemplatePar |check |template=Template:Infobox_drug |all= |opt= pronounce= pronounce_ref= pronounce_comment= ATC_prefix= ATC_suffix= ATC_supplemental= ATCvet= biosimilars= CAS_number_Ref= CAS_number= CAS_supplemental= ChEBI= ChEBI_Ref= ChEMBL_Ref= ChEMBL= ChemSpiderID= ChemSpiderID_Ref= chirality= class= container_only= DailyMedID= data_page= DrugBank_Ref= DrugBank= Drugs.com= duration_of_action= INN= INN_EMA= IUPAC_name= IUPHAR_ligand= KEGG_Ref= KEGG= MedlinePlus= NIAID_ChemDB= PDB_ligand= PubChemSubstance= PubChem= StdInChIKey_Ref= StdInChIKey= StdInChI_Ref= StdInChI_comment= StdInChI= UNII_Ref= UNII= DTXSID= Verifiedfields= Watchedfields= addiction_liability= alt2= altL= altR= alt= bioavailability= boiling_high= boiling_notes= boiling_point= captionLR= caption= caption2= charge= chemical_formula= chemical_formula_ref= chemical_formula_comment= class1= class2= class3= class4= class5= class6= component1= component2= component3= component4= component5= component6= density= density_notes= dependency_liability= drug_name= elimination_half-life= engvar= excretion= image2= imageL= imageR= image= image_class= image_class2= image_classL= image_classR= Jmol= legal_AU= legal_BR= legal_CA= legal_DE= legal_EU= legal_NZ= legal_UK= legal_UN= legal_US= legal_AU_comment= legal_BR_comment= legal_CA_comment= legal_DE_comment= legal_UK_comment= legal_NZ_comment= legal_US_comment= legal_UN_comment= legal_EU_comment= legal_status= licence_CA= licence_EU= licence_US= license_CA= license_EU= license_US= mab_type= melting_high= melting_notes= melting_point= metabolism= metabolites= molecular_weight= molecular_weight_round= molecular_weight_unit= molecular_weight_ref= molecular_weight_comment= onset= pregnancy_AU= pregnancy_AU_comment= pregnancy_category= protein_bound= routes_of_administration= SMILES= smiles= solubility= sol_units= source= specific_rotation= synonyms= target= tradename= type= vaccine_type= verifiedrevid= width2= widthL= widthR= width= AAN= BAN= JAN= USAN= source_tissues= target_tissues= receptors= agonists= antagonists= precursor= biosynthesis= gt_target_gene= gt_vector= gt_nucleic_acid_type= gt_editing_method= gt_delivery_method= sec_combustion= Ac=Ag=Al=Am=Ar=As=At=Au=B=Ba=Be=Bh=Bi=Bk=Br=C=Ca=Cd=Ce=Cf=Cl=Cm=Cn=Co=Cr=Cs=Cu= D=Db=Ds=Dy=Er=Es=Eu=F=Fe=Fl=Fm=Fr=Ga=Gd=Ge=H=He=Hf=Hg=Ho=Hs=I=In=Ir=K=Kr=La=Li=Lr=Lu=Lv= Mc=Md=Mg=Mn=Mo=Mt=N=Na=Nb=Nd=Ne=Nh=Ni=No=Np=O=Og=Os=P=Pa=Pb=Pd=Pm=Po=Pr=Pt=Pu=Ra=Rb=Re=Rf=Rg=Rh=Rn=Ru=S=Sb=Sc=Se=Sg=Si=Sm=Sn=Sr=Ta=Tb=Tc=Te=Th=Ti=Tl=Tm=Ts=U=V=W=Xe=Y=Yb=Zn=Zr= index_label= index2_label= index_comment= index2_comment= CAS_number2= CAS_supplemental2= ATC_prefix2= ATC_suffix2= ATC_supplemental2= PubChem2= PubChemSubstance2= IUPHAR_ligand2= DrugBank2= ChemSpiderID2= UNII2= KEGG2= ChEBI2= ChEMBL2= PDB_ligand2= NIAID_ChemDB2= SMILES2= smiles2= StdInChI2= StdInChIKey2= CAS_number2_Ref= ChEBI2_Ref= ChEMBL2_Ref= ChemSpiderID2_Ref= DrugBank2_Ref= KEGG2_Ref= StdInChI2_Ref= StdInChIKey2_Ref= UNII2_Ref= DTXSID2= QID= QID2=PLLR= pregnancy_US= pregnancy_US_comment= |cat=Pages using infobox drug with unknown parameters |format=0|errNS=0

|preview=

@@@ (See parameter list). This message only shows in Preview, it will not show after you do Template:Button.

}}{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals={{#invoke:ParameterCount |main |component1 |component2 |component3 |component4|component5|component6 }} | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=91112O=C(OCC)c1ccc(N)cc11S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3BLFLLBZGZJTVJG-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data=Template:Ubl Topical, OralAnbesol, Lanacane, Orajel, othersC05Template:ATC, Template:ATCvet, Template:ATC, Template:ATC | _legal_data=GSL, POTC

| _other_data=Ethyl 4-aminobenzoate

| _image_0_or_2 = Benzocaine.svgBenzocaine-from-xtal-3D-balls.png | _image_LR =

| _datapage = Benzocaine (data page) | _vaccine_target={{#ifeq: | vaccine | | _type_not_vaccine }} | _legal_all=GSL, POTC | _ATC_prefix_supplemental=C05Template:ATC, Template:ATCvet, Template:ATC, Template:ATC | _has_EMA_link = | CAS_number=94-09-7 | PubChem=2337 | ChemSpiderID=13854242 | ChEBI=116735 | ChEMBL=278172 | DrugBank=DB01086 | KEGG=D00552 | _hasInChI_or_Key={{#if:1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3BLFLLBZGZJTVJG-UHFFFAOYSA-N |yes}} | UNII=U3RSY48JW5 | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs={{#invoke:ParameterCount |main |CAS_number2 |ATC_prefix2 |PubChem2 |PubChemStructure2 |IUPHAR_ligand2 |DrugBank2 |ChemSpiderID2 |UNII2 |KEGG2 |ChEBI2 |ChEMBL2 |PDB_ligand2 |NIAID_ChemDB2 |SMILES2 |smiles2 |StdInChI2 |StdInChIKey2 |DTXCID2}} | _countIndexlabels={{#invoke:ParameterCount |main |index_label |index2_label}} | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields=changed |verifiedrevid=457480862}}

Benzocaine, sold under the brand name Orajel amongst others, is a local anesthetic, belonging to the amino ester drug class, commonly used as a topical painkiller or in cough drops. It is the active ingredient in many over-the-counter anesthetic ointments such as products for oral ulcers. It is combined with antipyrine to form A/B ear drops. In the US, products containing benzocaine for oral application are contraindicated in children younger than two years old.<ref name=FDA2018>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> In the European Union, the contraindication applies to children under 12 years of age.Template:Medical citation needed

It was first synthesised in 1890 in Germany and approved for medical use in 1902.<ref name=Fis2006>Template:Cite book</ref>

Medical usesEdit

Benzocaine is indicated to treat a variety of pain-related conditions. It may be used for:

  • Local anesthesia of oral and pharyngeal mucous membranes (sore throat, cold sores, mouth ulcers, toothache, sore gums, denture irritation)<ref name="ReferenceA">AHFS Drug Information 2007. McEvoy GK, ed. Benzocaine. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2844-5.</ref>
  • Otic pain (earache)<ref name="ReferenceA" />
  • Surgical or procedural local anesthesia<ref>Sultan Healthcare. Topex metered spray (benzocaine 20%) prescribing information. Englewood, NJ; 2006.</ref>
  • Relief of skin pain caused by sunburn, ingrown toenails, hemorrhoids, <ref>Benzocaine topical</ref>

Examples of combination medications of benzocaine include:

|CitationClass=web }}</ref>

  • Cepacol consists of menthol and benzocaine, and is used to treat sore throat.<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

Other usesEdit

File:Jiffy Toothache Drops bottle.jpg
Jiffy Toothache Drops bottle (7.75% Benzocaine)

Benzocaine is used as a key ingredient in numerous pharmaceuticals:

  • Some glycerol-based ear medications for use in removing excess wax as well as relieving ear conditions such as otitis media and swimmer's ear.
  • Some previous diet products such as Ayds.
  • Some condoms designed to prevent premature ejaculation. Benzocaine largely inhibits sensitivity on the penis, and can allow for an erection to be maintained longer (in a continuous act) by delaying ejaculation. Conversely, an erection will also fade faster if stimulus is interrupted.<ref>Template:Cite news</ref><ref>Template:Cite news</ref>
  • Benzocaine mucoadhesive patches have been used in reducing orthodontic pain.<ref>Template:Cite journal</ref>
  • In Poland it is included, together with menthol and zinc oxide, in the liquid powder (not to be confused with the liquid face powder) used mainly after mosquito bites. Today's ready-made Pudroderm<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref> was once used there as pharmaceutical compound.

Available formsEdit

Benzocaine can come in a variety of preparations including:

Oral preparations:

  • Lozenges (ex. Cepacol, Mycinettes)<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>Template:Failed verification

  • Throat Spray (ex. Ultra Chloraseptic)<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>

Topical preparations:

  • Aerosol (ex. Topex)<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>Template:Failed verification

  • Gel (ex. Orajel, Kank-A)<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>Template:Failed verification <ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

  • Paste (ex. Orabase)<ref>{{#invoke:citation/CS1|citation

|CitationClass=web }}</ref>Template:Failed verification

  • Cream (ex. Lanacane - active ingredient 3% Benzocaine)

Otic preparations:

  • Solution (ex. Allergen)

Side effectsEdit

Benzocaine is generally well tolerated and non-toxic when applied topically as recommended.<ref>Lexicomp Online, Adult and Pediatric Lexi-Drugs Online, Hudson, Ohio: Lexi-Comp, Inc.; 2013; April 15, 2013.</ref>

However, there have been reports of serious, life-threatening adverse effects (e.g., seizures, coma, irregular heart beat, respiratory depression) with over-application of topical products or when applying topical products that contain high concentrations of benzocaine to the skin.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Overapplication of oral anesthetics such as benzocaine can increase the risk of pulmonary aspiration by relaxing the gag-reflex and allowing regurgitated stomach contents or oral secretions to enter the airway.Template:Medical citation needed Applying an oral anesthetic and consuming beverages before going to bed can be particularly hazardous.Template:Medical citation needed

The topical use of higher concentration (10–20%) benzocaine products applied to the mouth or mucous membranes has been found to be a cause of methemoglobinemia, a disorder in which the amount of oxygen carried by the blood is greatly reduced.<ref>Template:Cite journal</ref> This side effect is most common in children under two years of age.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> As a result, the FDA has stated that benzocaine products should not be used in children under two years of age, unless directed by and supervised by a healthcare professional.<ref name="fda.gov">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> In European countries, the contraindication applies to children under 12 years of age. Symptoms of methemoglobinemia usually occur within minutes to hours of applying benzocaine, and can occur upon the first-time use or after additional use.<ref name="fda.gov" />

Benzocaine may cause allergic reactions.<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite news</ref> These include:

  • Contact dermatitis (redness and itchiness)<ref name="ReferenceB">Cetylite Industries. Cetacaine (benzocaine 14%, tetracaine 2% and butamben 2%) spray, gel and liquid prescribing information. Pennsauken, NJ; 2006 Sept.</ref>
  • Anaphylaxis (rare)<ref name="ReferenceB" />

PharmacologyEdit

PharmacodynamicsEdit

Pain is caused by the stimulation of free nerve endings. When the nerve endings are stimulated, sodium enters the neuron, causing depolarization of the nerve and subsequent initiation of an action potential. The action potential is propagated down the nerve toward the central nervous system, which interprets this as pain. Benzocaine acts to inhibit the voltage-gated sodium channels (VGSCs) on the neuron membrane, stopping the propagation of the action potential.Template:Citation needed

ChemistryEdit

Benzocaine is the ethyl ester of p-aminobenzoic acid (PABA). It can be prepared from PABA and ethanol<ref>Template:Cite journal</ref> by Fischer esterification or via the reduction of ethyl p-nitrobenzoate. Benzocaine is sparingly soluble in water; it is more soluble in dilute acids and very soluble in ethanol, chloroform, and ethyl ether. The melting point of benzocaine is 88–92 °C,<ref name="pubchem">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> and the boiling point is about 310 °C.<ref>Template:Cite book</ref> The density of benzocaine is 1.17 g/cm3.

Benzocaine is commonly found, particularly in Britain, as an additive in street cocaine and also as a bulking agent in "legal highs".<ref>Template:Cite news</ref> Benzocaine gives a numbing effect similar to cocaine and as a bulking and binding agent it can not be detected once mixed. It is the most popular cutting agent worldwide.<ref>Template:Cite news</ref>

Treatment of benzocaine with hydrazine leads to aminostimil, a compound related to isoniazid.

SynthesisEdit

Benzocaine can be prepared by esterification using 4-aminobenzoic acid and ethanol.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> It can also be prepared by reduction of ethyl 4-nitrobenzoate to the amine.<ref>Template:Cite journal</ref><ref>Template:OrgSynth</ref> In industrial practice, the reducing agent is usually iron and water in the presence of a little acid.<ref>Template:Cite book</ref>

HistoryEdit

Benzocaine was first synthesized in 1890 by the German chemist Eduard Ritsert (1859–1946),<ref>Biography of Eduard Ritsert (in German): Deutsche Biographie: Ritsert, Eduard.</ref> in the town of Eberbach<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> and introduced to the market in 1902 under the name "Anästhesin".<ref>Template:Cite book</ref><ref>Template:Cite journal See also: Template:Cite journal First published clinical study demonstrating the efficacy of benzocaine: Template:Cite journal</ref>

Veterinary medicineEdit

Bath solutions of benzocaine and its derivatives are commonly used to anesthetize amphibians for surgery.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> Benzocaine-based anesthetics are potent and highly effective for both anesthesia and euthanasia in amphibians.<ref>Template:Cite journal</ref>

ReferencesEdit

Template:Reflist

Template:Local anesthetics Template:Throat preparations Template:Vasoprotectives Template:Antipruritics Template:Ion channel modulators Template:Portal bar Template:Authority control